High Quality Tianeptine Sodium Pure Powder CAS. 30123-17-2 99% Purity

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >98%
• Model NO.: Tianeptine sodium
• CAS No.: 30123-17-2
• Mf: C21h24cln2nao4s
• Molecular Weight: 458.93
• Grade Standard: Medicine Grade
• Transport Package: Bottle, Can, Drum, Plastic Container, Vacuum Packe
• Specification: white powder
• Trademark: senwayer
• Origin: Wuhan, China
• HS Code: 2901100000
• Production Capacity: 2000kilograms Per Month

Product Description

High quality  Tianeptine Sodium pure powder  CAS. 30123-17-2 99% purity

Product Name:	Tianeptine Sodium
CAS:	30123-17-2
Molecular Formula:	C21H24ClN2NaO4S
Molecular Weight:	458.93
Grade Standard :	Medicine Grade
Purity:	98%min

 Tianeptine sodium salt is a salt of Tianeptine. Tianeptine, a tricyclic compound, is a selective facilitator of 5-HT (serotonin; sc-201146) uptake in vitro and in vivo. Additionally, Tianeptine is reported to act as a selective inhibitor of dopamine uptake . Tianeptine does not have a noted effect on monoamine uptake. In a study utilizing purified synaptosomes from rat brain, Tianeptine was reported to enhance serotonin uptake in selective brain regions. Purified synaptosomes were obtained from rats and incubated with tritium-labeled 5-HT and Tianeptine in vitro . The synaptosomes were then analyzed for uptake and release of 5-HT via a liquid scintillation.



Tianeptine is a drug used primarily in the treatment of major depressive disorder, although it may also be used to treat asthma or irritable bowel syndrome. Chemically it is a tricyclic antidepressant (TCA), but it has different pharmacological properties than typical TCAs as recent research suggests that tianeptine produces its antidepressant effects through indirect alteration of glutamate receptor activity (i.e., AMPA receptors and NMDA receptors) and release of BDNF, in turn affecting neural plasticity.

Tianeptine has antidepressant and anxiolytic (anti-anxiety) properties with a relative lack of sedative, anticholinergic and cardiovascular adverse effects, thus suggesting it is particularly suitable for use in the elderly and in those following alcohol withdrawal; such persons can be more sensitive to the adverse effects of psychotropic drugs. Recent results indicate possible anticonvulsant (anti-seizure) and analgesic (painkilling) activity of tianeptine via immediate or downstream modulation of adenosine A1 receptors (as the effects could be experimentally blocked by antagonists of this receptor).